All blog items

Our intestine is a highly complex organ – a tortuous, rugged channel built of many specialized cell-types and coated with a protective, slimy matrix. Yet the intestine begins as a simple tube consisting of a central lumen lined by a sheet of epithelial cells, which are smooth cells that lie on the surface of the lumen. These intestinal epithelial cells are central players in many human diseases.

A new way of producing the seasonal flu vaccine could speed up the process and provide better protection against infection. For decades, vaccine manufacturers have used chicken eggs to grow the flu virus strains included in the seasonal flu shot. But because these human strains frequently mutate to adapt to their new environment in eggs, the resulting vaccine is often an imperfect match to the actual virus that it is supposed to protect against.

The Duke Center for Applied Genomics and Precision Medicine is pleased to announce the first two post-doctoral fellows supported by an NIH training award (T32) in genomic medicine: Carolyn Baloh, MD, and Cory Stingl, MD.  Both fellows are from the Department of Pediatrics. Dr. Baloh will be working with Dr. Sandeep Dave, Professor, Department of Medicine, Division of Hematologic Malignancies & Cellular Therapy. Dr.

The 2017 class of Duke’s Master of Management in Clinical Informatics program recently spent three days in Washington, DC, discussing healthcare policy and innovation with stakeholders from across the industry. Class members participated in round-table discussions and listened to presentations from thirteen industry leaders, including private-sector and nonprofit CEOs, policy advisors and fellows, Department of Defense medical innovation officers, and former congressmen.

Call for Applications for Fund to Retain Clinical Scientists at Duke

HEALTHCARE TRANSFORMATION

With a study watch on her wrist and a sleep sensor in her new tote bag, a Caucasian woman in her 40s walked out of the Duke University Medical Center around 5:30 p.m. Thursday, July 13 as the first participant enrolled in the Project Baseline study in Durham.

Full Article: http://bit.ly/2udRtAR Excerpts from the article:  . . . To make the most of genomic information in practice, clinicians need convenient access to relevant genomic information about their patients.

DURHAM, N.C. – Mutations in the BRCA gene correspond to a higher lifetime risk of developing breast and ovarian cancers, and many women who carry these mutations consider undergoing mastectomy or removal of the ovaries and fallopian tubes as preventive measures.